Skip to main content
Clinical Trials/NCT01122862
NCT01122862CompletedPhase 2

A Clinical Study to Evaluate the Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth

GlaxoSmithKline1 site in 1 country23 target enrollmentStarted: April 2010Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
23
Locations
1
Primary Endpoint
Plaque Index of Test Mouth Rinse Versus Sterile Water After Day 4 of Treatment Administration

Study Overview

Brief Summary

A clinical study to evaluate the effect of a commercial mouth rinse on plaque re-growth

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Good general and oral health
  • At least 20 natural gradable teeth
  • Mean plaque score (Turesky Modification of the Quigley Hein Index) of greater than or equal to 2.00 at the first baseline visit

Exclusion Criteria

  • Not provided

Arms & Interventions

Sterile Water

Placebo Comparator

Sterile Water

Intervention: Sterile water (Other)

0.12% Chlorhexidine Mouthrinse

Active Comparator

Commercially available 0.12% Chlorhexidine mouthrinse

Intervention: 0.12% chlorhexidine mouthrinse (Drug)

Cosmetic mouthrinse

Active Comparator

Commercially available cosmetic mouthrinse

Intervention: Cosmetic mouthrinse (Other)

Outcomes

Primary Outcomes

Plaque Index of Test Mouth Rinse Versus Sterile Water After Day 4 of Treatment Administration

Time Frame: Day 4 post treatment administration

Plaque scores were assessed using Turesky Modification of the Quigley Hein Index and categorized as 0: No plaque; 1: Slight flecks of plaque at the cervical margin of the tooth;2: A thin continuous band of plaque (1 mm or smaller) at the cervical margin of the tooth;3: A band of plaque wider than 1 mm but covering less than 1/3 of the crown of the tooth;4: Plaque covering at least 1/3 but less than 2/3 of the crown of the tooth;5: Plaque covering 2/3 or more of the crown of the tooth. The interproximal plaque index was calculated by taking the average of plaque scores over the mesiofacial, distofacial, mesiolingual and distolingual surfaces in the upper and lower jaws for a participant.

Secondary Outcomes

  • Plaque Index Score of Test Mouth Rinse Versus Chlorhexidine Mouth Rinse After Day 4 of Treatment Administration(Day 4 post treatment administration)
  • Plaque Index After 24 Hours of Treatment Administration(Day 1 post treatment administration)
  • Interproximal Plaque Index After Day 4 of Treatment Administration(Day 4 post treatment administration)
  • Interproximal Plaque Index After 24 Hours of Treatment Administration(Day 1 post treatment administration)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials